Intravitreal Injection of Triamcinolone Acetonide for Macular Edema Due to Retinitis Pigmentosa and Other Retinal Diseases

  • Changguang Wang
  • Jianbin Hu
  • Paul S. Bernstein
  • Michael P. Teske
  • Marielle Payne
  • Zhenglin Yang
  • Chumei Li
  • David Adams
  • Jennifer H. Baird
  • Kang Zhang
Part of the Advances in Experimental Medicine and Biology book series (volume 572)

Abstract

Macular edema is a swelling of the macula that can result in decreased visual acuity. Because the macula is extensively surrounded by blood vessels, any resulting leakage can lead to macular edema and subsequent visual loss. Such leakage can be secondary to retinitis pigmentosa, and other retinal diseases including diabetic retinopathy, retinal vein occlusion, inflammatory processes such as uveitis, or can be a result of ocular surgery, referred to as Irvine-Gass Syndrome.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Antcliff, R.J., Spalton, D.J., Stanford, M.R., Graham, E.M., Ffytche, T.J. & Marshall, J. (2001). Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study. Ophthalmology, 108:765–72.PubMedCrossRefGoogle Scholar
  2. Beer, P.M., Bakri, S.J., Singh, R.J., Liu, W., Peters, G.B., 3rd & Miller, M. (2003). Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection. Ophthalmology, 110:681–6.PubMedCrossRefGoogle Scholar
  3. Bresnick, G.H. (1983). Diabetic maculopathy. A critical review highlighting diffuse macular edema. Ophthalmology, 90:1301–17.PubMedGoogle Scholar
  4. Bresnick, G.H. (1986). Diabetic macular edema. A review. Ophthalmology, 93:989–97.PubMedGoogle Scholar
  5. Brooks, H.L., Jr., Caballero, S., Jr., Newell, C.K., Steinmetz, R.L., Watson, D., Segal, M.S., Harrison, J.K., Scott, E.W. & Grant, M.B. (2004). Vitreous levels of vascular endothelial growth factor and stromal-derived factor 1 in patients with diabetic retinopathy and cystoid macular edema before and after intraocular injection of triamcinolone. Arch Ophthalmol, 122:1801–7.PubMedCrossRefGoogle Scholar
  6. Funatsu, H., Yamashita, H., Ikeda, T., Mimura, T., Eguchi, S. & Hori, S. (2003). Vitreous levels of interleukin-6 and vascular endothelial growth factor are related to diabetic macular edema. Ophthalmology, 110:1690–6.PubMedCrossRefGoogle Scholar
  7. Heckenlively, J.R., Jordan, B.L. & Aptsiauri, N. (1999). Association of antiretinal antibodies and cystoid macular edema in patients with retinitis pigmentosa. Am J Ophthalmol, 127:565–73.PubMedCrossRefGoogle Scholar
  8. Hockley, D.J., Tripathi, R.C. & Ashton, N. (1979). Experimental retinal branch vein occlusion in rhesus monkeys. III. Histopathological and electron microscopical studies. Br J Ophthalmol, 63:393–411.PubMedGoogle Scholar
  9. Ip, M.S., Gottlieb, J.L., Kahana, A., Scott, I.U., Altaweel, M.M., Blodi, B.A., Gangnon, R.E. & Puliafito, C.A. (2004). Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion. Arch Ophthalmol, 122:1131–6.PubMedCrossRefGoogle Scholar
  10. Jonas, J.B., Degenring, R.F., Kamppeter, B.A., Kreissig, I. & Akkoyun, I. (2004). Duration of the effect of intravitreal triamcinolone acetonide as treatment for diffuse diabetic macular edema. Am J Ophthalmol, 138:158–60.PubMedCrossRefGoogle Scholar
  11. Jonas, J.B., Kreissig, I., Sofker, A. & Degenring, R.F. (2003). Intravitreal injection of triamcinolone for diffuse diabetic macular edema. Arch Ophthalmol, 121:57–61.PubMedCrossRefGoogle Scholar
  12. Klein, R., Klein, B.E., Moss, S.E., Davis, M.D. & DeMets, D.L. (1984). The Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edema. Ophthalmology, 91:1464–74.PubMedGoogle Scholar
  13. Martidis, A., Duker, J.S., Greenberg, P.B., Rogers, A.H., Puliafito, C.A., Reichel, E. & Baumal, C. (2002). Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology, 109:920–7.PubMedCrossRefGoogle Scholar
  14. Massin, P., Audren, F., Haouchine, B., Erginay, A., Bergmann, J.F., Benosman, R., Caulin, C. & Gaudric, A. (2004). Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial. Ophthalmology, 111:218–24; discussion 224-5.PubMedCrossRefGoogle Scholar
  15. Sallum, J.M., Farah, M.E. & Saraiva, V.S. (2003). Treatment of cystoid macular edema related to retinitis pigmentosa with intravitreal triamcinolone acetonide: case report. Adv Exp Med Biol, 533:79–81.PubMedGoogle Scholar
  16. Saraiva, V.S., Sallum, J.M. & Farah, M.E. (2003). Treatment of cystoid macular edema related to retinitis pigmentosa with intravitreal triamcinolone acetonide. Ophthalmic Surg Lasers Imaging, 34:398–400.PubMedGoogle Scholar
  17. Yoshikawa, K., Kotake, S., Ichiishi, A., Sasamoto, Y., Kosaka, S. & Matsuda, H. (1995). Posterior sub-Tenon injections of repository corticosteroids in uveitis patients with cystoid macular edema. Jpn J Ophthalmol, 39:71–6.PubMedGoogle Scholar
  18. Zamir, E., Read, R.W., Smith, R.E., Wang, R.C. & Rao, N.A. (2002). A prospective evaluation of subconjunctival injection of triamcinolone acetonide for resistant anterior scleritis. Ophthalmology, 109:798–805; discussion 805-7.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, Inc. 2006

Authors and Affiliations

  • Changguang Wang
    • 1
    • 2
  • Jianbin Hu
    • 1
    • 2
  • Paul S. Bernstein
    • 1
  • Michael P. Teske
    • 1
  • Marielle Payne
    • 1
    • 2
  • Zhenglin Yang
    • 1
    • 2
  • Chumei Li
    • 1
    • 2
  • David Adams
    • 1
    • 2
  • Jennifer H. Baird
    • 1
    • 2
  • Kang Zhang
    • 1
    • 2
  1. 1.Moran Eye Center, Department of Ophthalmology and Visual ScienceUniversity of UtahSalt Lake City
  2. 2.Program in Human Molecular Biology & Genetics, Eccles Institute of Human GeneticsUniversity of UtahSalt Lake City

Personalised recommendations